Autologous Tumor Cell Vaccine
A therapeutic agent produced by isolating tumor cells from an individual and processing these tumor cells into a vaccine formulation in vitro; the vaccine is then administered to the individual from whom the tumor cells were isolated. Typically combined with an adjuvant immunostimulant, an autologous cell vaccine may elicit a cytotoxic T-lymphocytic immune response to cell surface-expressed tumor-associated antigens (TAAs), resulting in tumor cell death. (NCI04) [ ]
Term info
Autologous Tumor Cell Vaccine
- AC vaccine
- Autologous Cell Vaccine
- Autologous Tumor Cell Vaccine
NCIT_C116978, NCIT_C128784, NCIT_C116977
CTRP
Autologous Tumor Cell Vaccine
Autologous_Cell_Vaccine
43554
Autologous Tumor Cell Vaccine
Pharmacologic Substance, Immunologic Factor, Cell
C0879266
C1980
Term relations
- Autologous Tumor Cell Vaccine/BCG
- Autologous Dendritic Cells/Autologous Tumor Cell Vaccine/Sargramostim
- Autologous Tumor Cell Vaccine/Interleukin-2
- Autologous Tumor Cell Vaccine/Keyhole Limpet Hemocyanin/Sargramostim
- Autologous Tumor Cell Vaccine/Sargramostim
- Autologous Tumor Cell Vaccine/CD40-Ligand/Interleukin-2 Gene